TEOXANE
14Patents
14Active
14Granted
49Portfolio score
Filing activity: May 7, 2010 → Aug 26, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9421198B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 5 | Active |
| US9789226B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 4 | Active |
| US9498562B1 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 4 | Active |
| US9925309B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 2 | Active |
| US10413637B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 0 | Active |
| US10132734B2 | Process for evaluating the mechanical performance of a filler gel | Physics | 0 | Active |
| US11311472B2 | Topical composition comprising crosslinked hyaluronic acid and a polyacrylate compound | Human Necessities | 0 | Active |
| US10786601B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 0 | Active |
| US10307512B2 | Process for preparing hydrogels | Chemistry; Metallurgy | 0 | Active |
| US11406738B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 0 | Active |
| US9353194B2 | Process for preparing a crosslinked hyaluronic acid gel via homogenization in a deformable pouch | Chemistry; Metallurgy | 0 | Active |
| US10322212B2 | Composition comprising hyaluronic acid and mepivacaine | Human Necessities | 0 | Active |
| US9907739B2 | Dermal injectable sterile composition | Human Necessities | 0 | Active |
| US9393189B2 | Process of preparing a crosslinked gel | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.